Related Experiment Videos
Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis
Hagen Blaszyk1, Linan Wang, Wolfgang Dietmaier
1Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota, USA. hagen.blaszyk@klinik.uni-regensburg.de
Summary
Upper tract urothelial carcinoma may indicate hereditary nonpolyposis colorectal cancer syndrome. Microsatellite instability in these tumors correlates with other cancers and family history, but not survival.
Area of Science:
- Uro-oncology
- Cancer genetics
- Molecular pathology
Background:
- Hereditary nonpolyposis colorectal cancer syndrome (Lynch syndrome) is linked to DNA mismatch repair gene mutations and microsatellite instability.
- Urothelial carcinoma of the renal pelvis and ureter can be a manifestation of this hereditary cancer syndrome.
Purpose of the Study:
- To investigate microsatellite instability (MSI) in upper tract urothelial carcinoma (UTUC).
- To correlate MSI with clinicopathologic features and patient history of other cancers.
Main Methods:
- Analysis of microsatellite instability in 114 UTUC patients' tumor and normal DNA.
- Correlation of MSI status with clinical data, including additional nonurologic cancers and family cancer history.
- Evaluation of grade, stage, and MSI as predictors of cancer-specific survival.
Main Results:
- Microsatellite instability was detected in 31.3% of evaluable UTUC tumors, the highest frequency reported to date.
- Patients with MSI-unstable UTUC were more likely to have additional nonurologic cancers (especially colorectal) and a family history of colorectal cancer.
- Higher grade UTUC was also associated with MSI, but MSI status did not predict cancer-specific survival; grade and stage were stronger predictors.
Conclusions:
- UTUC exhibits a high frequency of MSI, suggesting it can serve as a marker for hereditary nonpolyposis colorectal cancer syndrome.
- Identifying MSI in UTUC patients is crucial for detecting Lynch syndrome and initiating surveillance in affected individuals and their relatives.